tiprankstipranks
Trending News
More News >
PremiumRatingsKyverna Therapeutics: Strong Clinical Progress and Regulatory Alignment Support Buy Rating
1M ago
Premium
Company Announcements
Kyverna Therapeutics Reports Q1 2025 Progress and Outlook
2M ago
Premium
Ratings
Kyverna Therapeutics: Strategic Advancements and Clinical Progress Drive Buy Rating
2M ago
Kyverna Therapeutics price target lowered to $12 from $13 at UBS
PremiumThe FlyKyverna Therapeutics price target lowered to $12 from $13 at UBS
3M ago
Premium
Company Announcements
Kyverna Therapeutics Advances CAR T-Cell Therapy Trials
3M ago
Kyverna Therapeutics files $250M mixed securities shelf
Premium
The Fly
Kyverna Therapeutics files $250M mixed securities shelf
3M ago
PremiumClass ActionLost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky LLP
7M ago
JPMorgan healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
7M ago
Kyverna shares remain ‘significantly under-valued,’ says JPMorgan
Premium
The Fly
Kyverna shares remain ‘significantly under-valued,’ says JPMorgan
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100